MA47193A - SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE - Google Patents

SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE

Info

Publication number
MA47193A
MA47193A MA047193A MA47193A MA47193A MA 47193 A MA47193 A MA 47193A MA 047193 A MA047193 A MA 047193A MA 47193 A MA47193 A MA 47193A MA 47193 A MA47193 A MA 47193A
Authority
MA
Morocco
Prior art keywords
bace1
tetrahydropyridine
difluoromethyl
difluoro
phenyl
Prior art date
Application number
MA047193A
Other languages
French (fr)
Inventor
Karsten Juhl
Mauro Marigo
Lena Tagmose
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MA47193A publication Critical patent/MA47193A/en

Links

MA047193A 2014-11-10 2015-11-09 SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE MA47193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA201400648 2014-11-10

Publications (1)

Publication Number Publication Date
MA47193A true MA47193A (en) 2019-11-13

Family

ID=58688571

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047193A MA47193A (en) 2014-11-10 2015-11-09 SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE

Country Status (2)

Country Link
AR (1) AR102599A1 (en)
MA (1) MA47193A (en)

Also Published As

Publication number Publication date
AR102599A1 (en) 2017-03-08

Similar Documents

Publication Publication Date Title
IL246833A0 (en) Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA41265A (en) COMPOSITIONS FOR THE ADMINISTRATION OF ILÉO-JEJUNAL DRUGS.
DK3119397T3 (en) Heterocyclic compounds for use in the treatment of PI3K-gamma-mediated disorders
HRP20181698T1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
DK3102213T3 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
BR112016021012A2 (en) pharmaceutical compositions of therapeutically active compounds.
DK3882250T3 (en) TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE FOR USE IN THE TREATMENT OF BTK-MEDIATED DISORDERS
HRP20181332T1 (en) Benzimidazole derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA54716A (en) REDUCTION OF THE VISCOSITY OF PHARMACEUTICAL FORMULATIONS
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
BR112017013012A2 (en) indenyl compounds, pharmaceutical compositions and medical uses thereof
DK3313370T3 (en) Ophthalmological pharmaceutical composition
DE112015002229A5 (en) Formulations for the treatment of hyperthyroidism
MA47193A (en) SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
DK3423081T3 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASE
BR112016026443A2 (en) deuterated heterocyclic compounds, their uses, and pharmaceutical composition
HUP1400520A2 (en) Laquinimod salts useful for the preparation of pharmaceutical compositions
ES1135060Y (en) "PLOWED"